🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Join us and learn how the LiverAim project aims to combat the burden of chronic liver disease: early diagnosis and efficient linkage to care! 🗓️:12th Dec 17:30-18:15 CET Register for the webinar! t.ly/yZTI8 Innovative Health Initiative IDIBAPS EASLnews European Liver Patients' Association NASH AWARE

❤️‍🩹Last Editorial as Editor-in-Chief of Journal of Hepatology 🎬Moving account of the outgoing Editor Paolo Angeli 🗻 The ups and downs ✂️ Difficult decisions (acceptance 8%) 🙏 Thankful that he steered this mighty ship skillfully to newer heigths EASLnews 🔗journal-of-hepatology.eu/article/S0168-…

LiverAim team meeting at #TLM2024 in San Diego 🇺🇸 Informal update about project progresses and next steps. Innovative Health Initiative AASLD

🚨Only 5 days left! 🗓️12th Dec 17:30-18:15 CET Discover the #LIVERAIM project and its groundbreaking approach to tackling the silent epidemic of #chronicliverdiseases! 🔗Register now! t.ly/yZTI8 #livertwitter #beatingliverdisease #innovationinlivercare

Merry Christmas and Happy, Healthy New Year from the LIVERAIM team! 🎄 🎅 💫 #liverTwitter #HealthyHolidays #LiverHealth

📬 First #LIVERAIM Newsletter is out! 👉Discover key highlights of our journey to date lnkd.in/eDm5fCBx #LiverTwitter #LIVERAIMNewsletter #BeatingLiverDiseases Jeffrey V. Lazarus Maja Thiele Aleksander Krag Salvatore Piano Jörn Schattenberg Innovative Health Initiative EASLnews European Liver Patients' Association

❌💊 Simvastatin + rifaximin does not prevent ACLF development in decompensated cirrhosis ⏳10 years of work in the books 💪🏼 Salvatore Piano Giacomo Zaccherini Kohilan Gananandan Frank Uschner Jonel Trebicka Ruben Hernaez Juan G Abraldes Jordi Gratacós Ginès Koos de Wit EASLnews AASLD

#Chronicliverdisease is a public health thread. #earlydiagnosis can improve patients' outcomes & QoL. ❓What does an early diagnosis mean for patients, families & caregivers? 🗓️3 March 17:30-18:10 CET 👉 Join the second #LIVERAIM webinar! liveraim.eu/2025/02/10/ear…

🚨The second #LIVERAIM webinar is on the way! "Early diagnosis of chronic liver disease - What does it mean for patients?" 🗓️ 3 March 17:30-18:10 CET 🔗Register now! liveraim.eu/2025/02/10/ear… #livertwitter #earlydiagnosis #changingtheparadigm

⌛️4 day left! 🔗Join 2nd #LIVERAIM webinar and discover what patients really think about #earlydiagnosis: the hopes, the fears, and the reality! 🗓️3 March 17:30-18:10 CET 👉Register now! tinyurl.com/bdhyjv8e #livertwitter #beatingliverdisease #changingtheparadigm

🚀#LIVERAIM is on the move! Biomarker analysis for early liver fibrosis detection has started at #CORELAB of Hospital Clínic on 22k+ serum samples from general and high-risk populations. 🔎Watch how science is shaping the future! #livertwitter Innovative Health Initiative IDIBAPS EASLnews

🌎Did you know 1 in 3 adults worldwide has #MASLD? It’s tied to obesity, diabetes & high cholesterol, it can lead to fibrosis and cancer. This World Liver Day remember: 🥦#FoodIsMedicine! 💪Let's make #liverhealth a priority1 Innovative Health Initiative #LIVERAIM

Now happening at #EASL2025 Jörn Schattenberg and ELISA POSE highlighting the LiverAim project at EASL track Hub 8. EASLnews Innovative Health Initiative

🩸 New data add to current evidence on #PlasmaExchange in ACLF: TPE may improve short-term survival in selected patients unresponsive ☞ More work needed to define who benefits & when #LiverTwitter #EASL #INASL #EFCLIF jcehepatology.com/article/S0973-…

Today at the municipality of Riese Pio X, in Italy, we screened over 110 citizens with Fibroscan and identified asymptomatic individuals at high risk of #liver disease. Liver diseases are silent and dangerous: prevention and early diagnosis make all the difference.